
Senjuti Saha on the health-care burden of RSV in Bangladesh
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
-
ナレーター:
-
著者:
このコンテンツについて
In a resource-constrained setting like Bangladesh, what proportion of a hospital's capacity is taken up with admissions for respiratory syncytial virus (RSV)? How many children needing admission are turned away every year because of lack of bed space? And how many of these "denials" and subsequent deaths might be prevented by the introduction of a maternal RSV vaccine or the monoclonal antibody nirsevimab?
Listen to Senjuti Saha, Deputy Executive Director of the Child Health Research Foundation, describe the results of her fascinating and potentially policy-changing study to our Editor-in-Chief, Zoë Mullan.
Read the full article:
https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(25)00048-8/fulltext?dgcid=buzzsprout_icw_podcast_May_25_langlo
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv